Signature Libraries

SL#001 Mcl-1 Apoptosis
SL#002 Bcl-xL Apoptosis
SL#003 Wnt/β-catenin Pathway Inhibitors
SL#004 Oncology Phenotypic Screening-1
SL#005 Ion Channel Modulators. Nav1.8-1
SL#006 Glycomimetics -1
SL#007 Glycomimetics -2
SL#008 Macrocyclic Glycomimetics-1
SL#009 Cell Permeable Macrocycles
SL#010 Purine-based Nucleosides-1
SL#011 MDM2-p53
SL#012 Wnt/β-catenin Pathway Activators
SL#013 Gram negative Antibacterials
SL#014 Peptide GPCR. SST4R agonists
SL#015 Ser-Thr Kinases
SL#016 Macrocyclic Glycomimetics-2
SL#017 Glycomimetics-3
SL#018 Spiro Peptidomimetics
SL#019 Soft Electrophiles-1
SL#020 Soft Electrophiles-2
SL#021 IDO1 inhibitors
SL#022 Soft Electrophiles-3
SL#023 Oncology Phenotypic Screening-2
SL#024 STAT3 inhibitors
SL#025 BH3 mimetics-1
SL#026 IRAK4 inhibitors
SL#027 Soft Electrophiles-4
SL#028 Glycomimetics-4
SL#029 IDH inhibitors
SL#030 α-Helix mimetics
SL#031 EZH2 inhibitors
SL#032 Macrocyclic BH3 mimetics
SL#033 PD-1/PD-L1 inhibitors
SL#034 Macrocyclic β-turn mimetics
SL#035 Oncology Phenotypic Screening-3
SL#036 Macrocyclic Glycomimetics-3
SL#037 Soft Electrophiles-5
SL#038 Glycomimetics/Immunology
SL#039 Macrocyclic Glycomimetics-4
SL#040 Constrained Tetrapeptides
SL#041 Voltage-gated sodium channels
SL#042 Protein lysine methyltransferase
SL#043 State 1(T) inhibitors of activated Ras
SL#044 CNS set (PAMPA BBB)
SL#045 HDAC inhibitors
SL#046 EGFR, PDGFR alpha & beta inhibitors
SL#047 BET inhibitors
SL#048 ApoE activators (agonist)
SL#049 SMO inhibitors
SL#050 Protease inhibitors
SL#051 Ion Channel Modulators. Nav1.8-2
SL#052 Purine-based Nucleosides-2
SL#053 Katanin inhibitors
SL#054 Menin-MLL inhibitors
SL#055, 056 Arabinose Glycomimetics - 1&2
SL#057, 058 Carbocyclic Glycomimetics - 1&2
SL#059, 060 Oxo-SpiroPyrrolidines - 1&2
Top